SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001628280-22-023625
Filing Date
2022-08-24
Accepted
2022-08-24 17:03:47
Documents
21

Document Format Files

Seq Description Document Type Size
1 10-12B/A a2022biohavenresearchltd-f.htm 10-12B/A 57743
2 EX-99.1 a2022biohavenresearchltdin.htm EX-99.1 2463675
3 bhl-igana.jpg GRAPHIC 234225
4 bhv-7000actionpotentiala.jpg GRAPHIC 21265
5 bhv-7000mxcurrenta.jpg GRAPHIC 87856
6 bhv-7000q2variantdomainsa.jpg GRAPHIC 81411
7 biohavenlabs1a.jpg GRAPHIC 200056
8 biohavenlabs2a.jpg GRAPHIC 182051
9 biohavenlabs3a.jpg GRAPHIC 71170
10 biohavenlabs4a.jpg GRAPHIC 95472
11 biohavenlabs5a.jpg GRAPHIC 189345
12 biohavenlabs6a.jpg GRAPHIC 142557
13 biohavenlabs7a.jpg GRAPHIC 251779
14 ourkv7platform1a.jpg GRAPHIC 47573
15 ourkv7platform2a.jpg GRAPHIC 23284
16 ourmyostatinplatform1a.jpg GRAPHIC 190519
17 picture1a.jpg GRAPHIC 21668
18 picture1copya.jpg GRAPHIC 41956
19 pipline88a.jpg GRAPHIC 193911
20 trpm31a.jpg GRAPHIC 77258
21 trpm32a.jpg GRAPHIC 82219
  Complete submission text file 0001628280-22-023625.txt   5603012
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Research Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-41477 | Film No.: 221192201
SIC: 2834 Pharmaceutical Preparations